443 related articles for article (PubMed ID: 11132386)
41. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
42. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
43. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.
Price RN; Uhlemann AC; van Vugt M; Brockman A; Hutagalung R; Nair S; Nash D; Singhasivanon P; Anderson TJ; Krishna S; White NJ; Nosten F
Clin Infect Dis; 2006 Jun; 42(11):1570-7. PubMed ID: 16652314
[TBL] [Abstract][Full Text] [Related]
44. Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia.
Jima D; Tesfaye G; Medhin A; Kebede A; Argaw D; Babaniyi O
East Afr Med J; 2005 Aug; 82(8):387-90. PubMed ID: 16261913
[TBL] [Abstract][Full Text] [Related]
45. In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand.
Pilz JB; Wernsdorfer G; Sirichaisinthop J; Rojanawatsirivet C; Wiedermann G; Wernsdorfer WH
Wien Klin Wochenschr; 2004; 116 Suppl 4():41-6. PubMed ID: 15683042
[TBL] [Abstract][Full Text] [Related]
46. Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.
Omari AA; Gamble C; Garner P
Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD005564. PubMed ID: 16235412
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children.
Yeka A; Lameyre V; Afizi K; Fredrick M; Lukwago R; Kamya MR; Talisuna AO
PLoS One; 2014; 9(12):e113311. PubMed ID: 25436614
[TBL] [Abstract][Full Text] [Related]
48. Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria.
Price R; Luxemburger C; van Vugt M; Nosten F; Kham A; Simpson J; Looareesuwan S; Chongsuphajaisiddhi T; White NJ
Trans R Soc Trop Med Hyg; 1998; 92(2):207-11. PubMed ID: 9764335
[TBL] [Abstract][Full Text] [Related]
49. An open randomized clinical trial of Artecom vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
Wilairatana P; Krudsood S; Chalermrut K; Pengruksa C; Srivilairit S; Silachamroon U; Treeprasertsuk S; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):519-24. PubMed ID: 12693586
[TBL] [Abstract][Full Text] [Related]
50. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine.
Brockman A; Price RN; van Vugt M; Heppner DG; Walsh D; Sookto P; Wimonwattrawatee T; Looareesuwan S; White NJ; Nosten F
Trans R Soc Trop Med Hyg; 2000; 94(5):537-44. PubMed ID: 11132385
[TBL] [Abstract][Full Text] [Related]
51. A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Saito M; Carrara VI; Gilder ME; Min AM; Tun NW; Pimanpanarak M; Viladpai-Nguen J; Paw MK; Haohankhunnatham W; Konghahong K; Phyo AP; Chu C; Turner C; Lee SJ; Duanguppama J; Imwong M; Bancone G; Proux S; Singhasivanon P; White NJ; Nosten F; McGready R
BMC Med; 2021 Jun; 19(1):132. PubMed ID: 34107963
[TBL] [Abstract][Full Text] [Related]
52. Compliance with a 2 day course of artemether-mefloquine in an area of highly multi-drug resistant Plasmodium falciparum malaria.
Na-Bangchang K; Congpuong K; Sirichaisinthop J; Suprakorb K; Karbwang J
Br J Clin Pharmacol; 1997 Jun; 43(6):639-42. PubMed ID: 9205825
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.
Ezzet F; van Vugt M; Nosten F; Looareesuwan S; White NJ
Antimicrob Agents Chemother; 2000 Mar; 44(3):697-704. PubMed ID: 10681341
[TBL] [Abstract][Full Text] [Related]
54. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination.
Nosten F; Luxemburger C; ter Kuile FO; Woodrow C; Eh JP; Chongsuphajaisiddhi T; White NJ
J Infect Dis; 1994 Oct; 170(4):971-7. PubMed ID: 7930743
[TBL] [Abstract][Full Text] [Related]
55. Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.
Ogutu B; Yeka A; Kusemererwa S; Thompson R; Tinto H; Toure AO; Uthaisin C; Verma A; Kibuuka A; Lingani M; Lourenço C; Mombo-Ngoma G; Nduba V; N'Guessan TL; Nassa GJW; Nyantaro M; Tina LO; Singh PK; El Gaaloul M; Marrast AC; Chikoto H; Csermak K; Demin I; Mehta D; Pathan R; Risterucci C; Su G; Winnips C; Kaguthi G; Fofana B; Grobusch MP
Lancet Infect Dis; 2023 Sep; 23(9):1051-1061. PubMed ID: 37327809
[TBL] [Abstract][Full Text] [Related]
56. Good efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in eastern Sumba, East Nusatenggara, Indonesia.
Sutanto I; Suprianto S; Widiaty A; Rukmiyati ; Ruckert P; von Bethmann A; de Monbrison F; Picot S; Laihad F; Baird JK
Acta Med Indones; 2012 Jul; 44(3):187-92. PubMed ID: 22983072
[TBL] [Abstract][Full Text] [Related]
57. Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.
Laman M; Moore BR; Benjamin JM; Yadi G; Bona C; Warrel J; Kattenberg JH; Koleala T; Manning L; Kasian B; Robinson LJ; Sambale N; Lorry L; Karl S; Davis WA; Rosanas-Urgell A; Mueller I; Siba PM; Betuela I; Davis TM
PLoS Med; 2014 Dec; 11(12):e1001773. PubMed ID: 25549086
[TBL] [Abstract][Full Text] [Related]
58. High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series.
Sondén K; Wyss K; Jovel I; Vieira da Silva A; Pohanka A; Asghar M; Homann MV; Gustafsson LL; Hellgren U; Färnert A
Clin Infect Dis; 2017 Jan; 64(2):199-206. PubMed ID: 27986683
[TBL] [Abstract][Full Text] [Related]
59. Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand.
Krudsood S; Chalermrut K; Pengruksa C; Srivilairit S; Silachamroon U; Treeprasertsuk S; Kano S; Brittenham GM; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):316-21. PubMed ID: 12971556
[TBL] [Abstract][Full Text] [Related]
60. Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan.
Elamin SB; Awad AI; Eltayeb IB; Elmardi KA; Hassan AH; Mohamed AO; Malik EM; Mohamad TA
Eur J Clin Pharmacol; 2010 Mar; 66(3):231-7. PubMed ID: 20187287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
